Analysis

Eli Lilly investors endured another bruising week as the pharmaceutical giant's stock slid nearly 5% on Friday, closing at €750....

ImmunityBio is posting its strongest-ever quarterly sales, yet the stock is heading in the opposite direction. The biotech group generated...

The Göppingen-based software group TeamViewer is riding a wave of sector-wide optimism, but beneath the surface, the company is grappling...

The final drill results of Antimony Resources' 2025 campaign have landed, and they do more than just extend known mineralization...

On paper, Ocugen has everything a small-cap biotech investor could want: seven buy ratings, zero holds or sells, and a...

The numbers are staggering. AMD shares closed at a fresh all-time high of €294.95 on Friday, capping a week that...

Amazon shares closed the trading week at a fresh all-time high of $263.99, surging 3.42% on Friday alone as investors...

The math is seductive. A single-digit price-to-earnings ratio. A $6 billion share buyback that would retire roughly 14% of the...

A cancelled order worth more than a billion dollars sent Oracle’s stock into a tailspin on Thursday, but the episode...

A brief technical breakout for Renk’s shares has unravelled, leaving the Augsburg-based drivetrain specialist to contend with a mix of...